I am accounted to Eular-2015 congress in Italy (Rome) for 6days(9-14 June 2015).

The Eular scientific sessions was very regular from 8Am to 6 PM hour.

I am very Interested for interview by some scientific or soscio-scientific Rheumatic disease - Associations So:

SLE , Scleroderma, Alkaptonuria,….

Overall Some key points Was very important for me.

1.     Early diagnosis and  prevention challenges in Rheumatic disease. So RA prevention (Primary prevention).

2.     Patient included research approaches in Rheumatic disease (RA or SLE , etc).

3.     No set of criteria, No imaging modality and no biomarker can  Replace the clinical judgment by an experienced clinician.